Status:
UNKNOWN
Identification and Measurement of Antioxidants and Cytokines in the Anterior Chamber of Various Ocular Disorders
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Eye Diseases
Eligibility:
All Genders
1-1 years
Brief Summary
This study offers evaluation and treatment for patients with corneal or retinal diseases, such as corneal opacities or diabetic retinopathy. The protocol is not designed to test new treatments; rather...
Detailed Description
The primary purpose of the protocol is to accumulate a cohort of patients with corneal or retinal diseases for possible participation in new CGMH clinical trials and epidemiological protocols. Also, b...
Eligibility Criteria
Inclusion
- Intravitreal injection of patients
- Patients with vitreoretinal surgery
- Corneal transplant patients
- General cataract surgery patients
Exclusion
- Those who have previously received aqueous extraction or intraocular surgery
- Eyeball infection patients
- Patients with uveitis
- Those with high intraocular pressure (\>40 mmHg) or too low (\<5 mmHg)
Key Trial Info
Start Date :
January 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04101591
Start Date
January 16 2019
End Date
July 31 2024
Last Update
September 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ChangGungMH
Taoyuan District, Taoyuan City, Taiwan, 333